V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryGRAS
Compliance · The complete guide

GRAS: Generally Recognized as Safe in US Food Regulation

In short

Understand the safety rationale, intended-use boundaries, regulatory documents, and human decisions behind an ingredient assessment.

4,160 words · ~19 min read
Food ingredient scientist in hair cover, mask, safety glasses and gloves reviewing an ingredient safety dossier on a tablet beside sample jars
On this page
  1. 01What GRAS means—and why the intended use matters
  2. 02GRAS, food additive regulation, notices, and supplier documents
  3. 03Scientific procedures and historical common use
  4. 04Map the intended product and market
  5. 05Separate the notification decision from notice contents
  6. 06Turn the assessment into manufacturing decisions
  7. 07Link the substance, intended use, evidence, and decision
  8. 08Worked cases: changed use, specific limits, and new evidence
  9. 09Connect reviewed conditions to formulation and change control
  10. 10Failure modes that weaken an otherwise useful assessment
  11. 11A practical review checklist before operational use
On this page · 11 sections
  1. 1What GRAS means—and why the intended use matters
  2. 2GRAS, food additive regulation, notices, and supplier documents
  3. 3Scientific procedures and historical common use
  4. 4Map the intended product and market
  5. 5Separate the notification decision from notice contents
  6. 6Turn the assessment into manufacturing decisions
  7. 7Link the substance, intended use, evidence, and decision
  8. 8Worked cases: changed use, specific limits, and new evidence
  9. 9Connect reviewed conditions to formulation and change control
  10. 10Failure modes that weaken an otherwise useful assessment
  11. 11A practical review checklist before operational use
AI · Explain it for MY operation

How does GRAS apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What GRAS means—and why the intended use matters

GRAS means generally recognized as safe: for substances intentionally added to US food, it describes recognition among qualified experts that a substance has been adequately shown to be safe under its intended conditions of use.

For substances intentionally added to US food, FDA’s explanation of GRAS under the FD&C Act describes GRAS as an exception to the food additive definition. This official overview explains the statutory boundary; it is not itself a binding regulation. The important qualifier is the intended use: GRAS does not describe unconditional safety for every application of an ingredient.

Define the use before applying the conclusion

As an operational recommendation, a manufacturer should keep a short scope record connecting the assessed substance to the proposed food application. This is a practical documentation approach, not a prescribed regulatory form. Make the record specific enough that a reviewer can compare the proposed manufacturing use with the use addressed by the safety assessment:

  • Substance identity: identify the material and the specification used in the assessment, rather than relying only on a commercial name.
  • Food application: identify the food category and the ingredient’s intended function.
  • Conditions of use: record the proposed use level, relevant processing conditions, and any boundaries stated in the assessment.

Use this scope record alongside broader HACCP planning or preventive-control planning, keeping the ingredient-use conclusion identifiable rather than treating it as a general statement about the whole manufacturing operation. A useful internal question is whether the material and application being considered actually match the documented assessment.

For US food ingredients, 21 CFR 170.30(d) states that the listed and affirmed ingredients do not encompass every substance that is GRAS for its intended use in food.

02GRAS, food additive regulation, notices, and supplier documents

For a US food ingredient review, separate the regulatory basis for use from the documents used to communicate or support it. The following comparison is a practical filing and review aid, not a list of interchangeable evidence.

Term or documentDecision it addressesScope to examineOperational use
Manufacturer’s GRAS conclusionManufacturer’s assessment of the intended useSubstance identity and assessed conditions of useCompare the proposed formulation with the assessment
GRAS noticeNotifier’s position communicated to FDANotified substance and intended useKeep the submission distinct from agency correspondence
Food additive regulationRegulatory basis being relied onIngredient and use covered by the cited regulationRecord the provision and compare it with the proposed use
Supplier specifications or certificates of analysisMaterial acceptance against purchasing or analytical criteriaMaterial identity, specification revision, lot and reported resultsSupport material review; link separately to the regulatory assessment

For US food ingredients, 21 CFR 170.30(g) requires a food additive regulation for an ingredient that is neither GRAS nor subject to a prior sanction.

For US human-food GRAS notices, 21 CFR 170.225(c)(6) requires the notifier to state its view that the substance is exempt from premarket approval based on its GRAS conclusion for the intended use. That statement expresses the notifier’s view, not an agency conclusion.

As a document-control practice, record supplier declarations and certificates as supporting commercial or analytical documents, with a separate field identifying the regulatory assessment they support. Do not assign regulatory status from a document title. Within the quality assurance process, assign a reviewer to resolve mismatches; use a recipe supersession log to identify the formulation version being compared.

03Scientific procedures and historical common use

Scientific evidence and general recognition

For US food ingredients assessed through scientific procedures, 21 CFR 170.30(b) requires the same quantity and quality of scientific evidence as is required to obtain food additive approval. The provision requires generally available and accepted scientific data, information, or methods, ordinarily published, together with scientific principles; unpublished material may corroborate that basis. The distinction is between evidence supporting safety and evidence supporting general recognition—not simply between having studies and having none.

As a review practice, assess those questions separately. Record what each study supports, then assess whether the scientific basis is accessible and accepted. A favorable internal study can contribute to the safety reasoning without, by itself, demonstrating that the reasoning is generally recognized.

Historical use has a defined boundary

For US food ingredients, 21 CFR 170.30(c)(1) provides that an ingredient not in common use in food before January 1, 1958, may achieve general recognition of safety only through scientific procedures. Familiarity or recent market presence does not establish that historical condition.

For US food ingredients relying on historical common use outside the United States, 21 CFR 170.30(c)(2) requires corroboration from a second, independent source confirming the history and circumstances of use. The documentation and corroborating information must be widely available in the country where that use occurred and readily available to interested qualified experts in the United States.

Recommended practice: an evidence register

Keep these review fields separate rather than reducing every reference to a favorable or unfavorable label:

  • Source availability: publication details, access restrictions, and how reviewers can retrieve the material.
  • Study findings: observations, methods, limitations, and uncertainty, without substituting the reviewer's conclusion for the reported result.
  • Intended-use relevance: the relationship to the assessed substance, food application, exposure, and consumer population.
  • Reviewer interpretation: the conclusion drawn, its rationale, unresolved questions, and whether the material supports safety, general recognition, or both.

This is a proposed scientific-review structure, not a prescribed study package. Keep it distinct from operational food-safety records; use the 21 CFR 117 overview when considering that separate manufacturing context.

04Map the intended product and market

This article centres on US food ingredient uses. Keep binding US food CFR provisions separate from FDA explanatory material. The scope map below is a proposed operational control, not a statement of adjacent regimes’ legal requirements.

Product or destinationIntended application and assessment to perform
Conventional foodIdentify the ingredient’s function and food category; compare the proposed use with the assessment’s scope.
Food-contact applicationsIdentify the packaging or processing-contact use; check current food-contact rules and the appropriate regulatory route.
Animal foodIdentify the target species and feed use; check current animal-food rules, including relevant animal-food manufacturing controls.
Dietary supplementsIdentify the ingredient’s role and finished-product category; check current supplement rules separately from supplement manufacturing controls.
Infant formulaIdentify the intended infant population and formula application; check current infant-formula rules before reusing an assessment.
Medicines or devicesIdentify the therapeutic or device application; obtain a product-specific regulatory review rather than treating a US food-use conclusion as authorization.
Non-US destinationsIdentify each destination and local product classification; check current market-specific rules, such as the relevant Health Canada framework, rather than treating US conclusions as foreign-market authorization.

Operational scope-control proposal: before reusing an assessment, record destination market, product category, intended function, applicable regulatory route, and responsible reviewer. Route uncertain classifications to that reviewer before adopting the assessment for the new application.

Proposed software support: store these fields with the assessment and flag mismatches for human review. This is a workflow design proposal, not a product capability claim or regulatory decision.

05Separate the notification decision from notice contents

Keep four questions separate: what supports the manufacturer’s conclusion, whether to notify FDA, what a submitted notice contains, and what subsequent FDA correspondence actually says. A practical record structure gives each question its own decision and supporting documents.

What supports the conclusion, and what goes into a notice?

For US human-food GRAS notices, selected Part 1 statements under 21 CFR 170.225(c) address the basis, accessibility, presentation, and ownership of the submission:

  • Statutory basis: Part 1 of a US human-food GRAS notice identifies the statutory basis for the conclusion under 21 CFR 170.225(c)(5). Refer back to the evidence routes covered above rather than treating notification as another evidence route.
  • Data access: a US human-food GRAS notice states agreement to make supporting data and information available to FDA on request, during or after evaluation, under 21 CFR 170.225(c)(7)(i).
  • Non-objection statement: Part 1 of a US human-food GRAS notice states the notifier’s view that the substance is not subject to premarket approval requirements, based on the notifier’s GRAS conclusion for the intended use, under 21 CFR 170.225(c)(6).
  • Disclosure position: a US human-food GRAS notice states the notifier’s view about whether information is exempt from disclosure under 21 CFR 170.225(c)(8). This is a statement of the notifier’s position, not an established confidentiality outcome.
  • Balanced submission: for US human-food GRAS notices, 21 CFR 170.225(c)(9) calls for certification that, to the notifier’s best knowledge, the notice is complete, representative, and balanced, including known pertinent unfavorable as well as favorable information.
  • Signer identity: a US human-food GRAS notice states the signer’s name and position or title under 21 CFR 170.225(c)(10).

FAQ: How should a no-questions letter be recorded?

Preserve FDA’s actual response wording and the assessed substance and intended use. Do not relabel a no-questions letter as an approval in a supplier register or internal workflow. Have a regulatory reviewer interpret the correspondence before changing an operational decision.

As a document-control practice, maintain linked but separate records for the manufacturer’s conclusion, submitted notice, and FDA correspondence. Use production context tagging to connect those records to the relevant material and use without collapsing them into one status field.

06Turn the assessment into manufacturing decisions

For manufacturers assessing ingredients for US food use, the following lifecycle is a suggested implementation pattern, not a legally prescribed sequence. Responsibilities are examples: assign named owners with suitable competence. The evidence and notice rules discussed earlier remain separate from these operational handoffs.

HandoffInputOutputExample accountable function
Define intended useProduct concept and proposed recipeAssessment scope: food category, function, use level and marketFormulation staff
Match the materialScope, supplier identity and specificationsDocumented match or identified identity gapsProcurement, supported by quality personnel
Review evidenceMatched material, intended use and evidenceScientific assessment and unresolved questionsScientific reviewers
Document the decisionScientific assessment and scopeSigned rationale, boundaries and any notification decisionRegulatory affairs
Hand off to operationsDocumented decision and reviewed conditionsControlled formulation and purchasing instructionsQuality personnel, with formulation and procurement
Review changesProposed changes or new evidenceDocumented impact assessment and dispositionRegulatory affairs, supported by scientific reviewers

Keep a review packet containing the assessment scope, linked specifications, an evidence index, the decision rationale, unresolved questions and any notification decision. Identify the human decision-maker and record which questions prevent operational use. The following section develops the underlying data relationships; this packet is the handoff summary.

Translate reviewed conditions into instructions that operators and buyers can apply: permitted formulation applications and addition levels, the material specification to purchase against, and substitution restrictions. Link these instructions through the quality assurance process to the relevant recipe and batch record, rather than leaving them only in a scientific report.

For unresolved scope or identity questions, record an explicit disposition—such as hold pending clarification or exclude the proposed use—and assign an owner. A generic approved-ingredient flag should not settle those questions. Route supplier, specification, process or intended-use changes, and new safety evidence, back to the appropriate reviewers before relying on the existing decision.

07Link the substance, intended use, evidence, and decision

The diagram below proposes a record structure for a US food GRAS assessment, not a regulatory submission template. Its purpose is to keep a conclusion attached to the material and use actually evaluated.

Substance specification + intended use → assessment ← evidence items; assessment ↔ correspondence; change review → affected records and assessment.

  • Substance specification: assign a stable identifier and controlled revision to the identity, composition, purity attributes and manufacturing description used in the evaluation.
  • Intended use: maintain a separately identified, revision-controlled record of food applications, use levels and relevant use conditions. Record units with every use-level value and document assumptions behind any exposure-related field.
  • Evidence item: retain the source document, its identifier, version and provenance. Store interpretation separately, linked to the assessment where it applies.
  • Assessment: reference the exact specification and intended-use revisions evaluated, linked evidence, reasoning, unresolved questions and the regulatory reviewer’s decision.
  • Correspondence: link communications to the relevant assessment and track their status independently from the reviewer’s conclusion.
  • Change review: identify affected records, assign a reviewer and record whether the assessment remains applicable or needs revision. Preserve earlier relationships rather than overwriting them.

An evidence item can support several assessments through separate relevance notes. Shared evidence does not make assessments interchangeable: each interpretation depends on its own material and use. This supports requirements traceability without duplicating source documents.

Keep the regulatory reviewer’s decision separate from operational material disposition, including batch release, and from correspondence status. Preserve the identity of each decision-maker, the decision date and the record revision considered; a shared status field would obscure those distinct responsibilities.

A Use-Specific Assessment Record

Substance Specification

Identifies the evaluated material.

  • ingredient_id
  • specification_revision
  • identity_description
  • composition_profile
  • impurity_profile

Intended Use

Defines the evaluated application.

  • intended_use_id
  • food_category
  • technological_function
  • use_level
  • use_level_unit
  • destination_market

Evidence Item

Separates findings from interpretation.

  • evidence_id
  • source_reference
  • availability_basis
  • finding_summary
  • reviewer_interpretation

Assessment

Preserves the human conclusion.

  • assessment_id
  • intended_use_id
  • specification_revision
  • evidence_ids
  • basis_route
  • conclusion
  • reviewer

Regulatory Correspondence

Retains communications separately.

  • correspondence_id
  • assessment_id
  • notice_reference
  • response_text
  • response_scope

Change Review

Tracks affected records and disposition.

  • change_id
  • affected_assessment_ids
  • change_reason
  • impact_evaluation
  • disposition
  • decision_owner
Suggested linked records, not a prescribed filing template.

08Worked cases: changed use, specific limits, and new evidence

These qualitative cases separate regulatory consequences from proposed internal review actions. The record checks and human dispositions are illustrative industry practice, not additional legal requirements or ingredient-specific safety conclusions.

Changed conditions under a GMP-only affirmation

Assumed facts: A US food ingredient is affirmed in part 184 or part 186 with no limitation other than good manufacturing practice. The proposed conditions differ significantly from those underlying the affirmation.

Controlling distinction: For this US food use, 21 CFR 170.30(i) says significantly different conditions may not be GRAS—not that every difference is disqualifying. The US food manufacturer cannot rely on that affirmation as authorization and must independently establish that the use is GRAS or use the substance in accordance with a food additive regulation.

Records and question: Compare the affirmation’s underlying conditions, proposed formulation, use instructions and safety assessment. What supports the changed use independently of the affirmation?

Proposed disposition: Regulatory and safety reviewers defer implementation while resolving the applicable basis. Quality then translates the reviewed conditions into formulation controls and ingredient-add verification.

Use outside specific affirmation limitations

Assumed facts: A US food ingredient has a specifically limited affirmation. The proposed application falls outside an established limitation.

Controlling distinction: For this US food use, 21 CFR 170.30(j) requires a food additive regulation when the use does not fully comply with every established limitation. This is not the GMP-only branch above.

Records and question: Compare the affirmation’s limitations with the product category, ingredient function and proposed use level. Does an applicable food additive regulation cover the proposed application?

Proposed disposition: Regulatory reviewers resolve coverage before implementation; formulation owners can instead propose a use within the established limitations. Quality records the accepted conditions in the batch record.

New information after a conclusion

Assumed facts: An assessment for a US food ingredient receives a newly relevant adverse finding after its conclusion.

Controlling distinction: For US food ingredients, 21 CFR 170.30(l) provides that new information may require reconsideration of GRAS status; it does not make every new finding an automatic status change.

Records and question: Examine the original assessment, the adverse finding, material identity and exposure assumptions. Does the finding undermine the conclusion for the actual intended use?

Proposed disposition: Safety specialists assess relevance and uncertainty; regulatory and quality owners document whether to retain, revise or suspend internal reliance on the conclusion, including any interim manufacturing restrictions.

Specifications and functional level for an affirmed use

Assumed facts: A US food ingredient is listed or affirmed as GRAS, and a manufacturer wants to confirm the use still qualifies beyond the affirmation regulation itself.

Controlling distinction: For this US food use, 21 CFR 170.30(h) adds requirements beyond the affirmation regulation: the ingredient must comply with any applicable Food Chemicals Codex specifications, must perform an appropriate function in the food, and must be used at a level no higher than necessary to achieve that intended purpose.

Records and question: Compare the ingredient's certificate of analysis against the applicable specification, document the technological function it performs in this product, and record why the proposed use level is no higher than needed.

Proposed disposition: Quality and formulation staff retain this comparison with the assessment record; regulatory reviewers revisit the conclusion if the specification, function, or use level later changes.

09Connect reviewed conditions to formulation and change control

A proposed integration design links formulation or product-lifecycle records, purchasing records, laboratory results, document control, and quality change records using the assessed specification revision and intended-use identifier as matching keys. Purchasing records point to the assessed material specification; formulation records carry the intended-use identifier; laboratory results retain the tested lot and specification revision. Document control holds the assessment reference and correspondence, while change control records proposed departures and reviewer decisions.

Exception eventQuestion routed to a human reviewer
Unmatched specification revisionMaterial or quality reviewer: does this revision match the material assessed, or does the difference need evaluation?
Changed intended applicationRegulatory reviewer: does the proposed application remain within the reviewed use?
Missing assessment referenceDocument owner: which authorized assessment supports this material-use combination?
Inconsistent correspondence statusRegulatory reviewer: which correspondence record supports the status, and which connected records need correction?

For recovery, identify affected formulations, purchase orders, lots, results, and documents. Review the discrepancy with the responsible technical, regulatory, and quality owners; record an authorized disposition; then synchronize the accepted revision across connected systems. Preserve superseded references and the reason for correction in the audit trail, rather than silently overwriting them. Confirm that downstream records now resolve to the accepted assessment before closing the exception.

Use the earlier worked cases for legal reasoning. Software serves only to organize evidence, route work, and preserve recorded decisions; designated people retain review, approval, and release decisions.

10Failure modes that weaken an otherwise useful assessment

These proposed quality-control checks address record integrity and review completeness; they are not separately mandated GRAS procedures. Assign each exception an owner and retain the observable result of its resolution.

FailureControlObservable result
Identity driftReconcile the current material specification with the identity and specification revision used in the assessment.Matched revisions, or a documented difference routed for assessment.
Unreviewed evidence itemReconcile the evidence register against the review queue, including the unfavorable evidence discussed earlier.Recorded reviewer disposition for each item; unresolved items retain an owner.
Unsupported status editingCheck editor authorization and the decision supporting each status change through an audit trail review workflow.Confirmed authorization and linked decision, or a corrected status with retained history.
Broken record linksValidate relationships between the substance, intended use, evidence, and signed assessment—not merely whether links open.Correct target records and revisions confirmed, or a documented unresolved exception.

Distinguish scientific disagreement from missing documentation when triaging data integrity exceptions. Disagreement needs substantive evaluation by the responsible scientific reviewer; repairing a link does not settle it. Missing documentation needs record recovery and confirmation of what was actually assessed. Keep the document categories discussed earlier distinct: recovering a supplier document does not establish that it was the basis of the assessment.

11A practical review checklist before operational use

Use this suggested internal checklist to prepare the assessment for a human decision, not to certify compliance.

From proposed use to controlled implementation
  1. 1
    Define intended useRecord the food application, function, market, and proposed conditions.
  2. 2
    Match Material IdentityAssociate the proposal with a specific ingredient specification revision.
  3. 3
    Organize EvidenceLink relevant findings, source availability, and reviewer interpretations.
  4. 4
    Evaluate the basisHave designated reviewers assess the rationale and unresolved questions.
  5. 5
    Record the decisionPreserve the human conclusion and separate notification decision.
  6. 6
    Transfer reviewed conditionsConnect accepted instructions to formulation and purchasing records.
  7. 7
    Review changesRoute affected assessments and operational records for documented disposition.
A suggested manufacturer workflow; accountable people evaluate evidence and authorize operational decisions.
  • Assessed identity: material identity and specifications match the assessment.
  • Intended-use scope: formulation, food category and use conditions remain within the reviewed scope.
  • Destination market: the reviewer has addressed the intended jurisdiction and product category.
  • Evidence links: references resolve to the versions actually reviewed.
  • Reviewer rationale: conclusions, uncertainties and decision authority are recorded.
  • Notification records: notices and agency correspondence are linked where applicable.
  • Operational instructions: purchasing, formulation and production instructions reflect reviewed conditions.
  • Unresolved exceptions: each open issue has an owner and disposition route in the quality risk register.

Record the outcome and next-action owner: ready for the designated human decision—designated approver; further scientific review needed—scientific reviewer; scope clarification needed—regulatory lead; or record correction needed—record owner.

Frequently asked questions

Q.Can an intended use be GRAS even if the ingredient does not appear in the CFR GRAS lists?+

Treat a list search as a starting point, not the complete assessment. For US food, FDA’s GRAS overview describes recognition among qualified experts of safety under the conditions of intended use as the relevant basis. As a manufacturer’s screening practice, request the reasoning supporting that particular use rather than relying on an ingredient name alone. Record unresolved questions in the quality risk register before accepting the supplier’s position.

Q.What should a manufacturer request when a supplier describes an ingredient as GRAS?+

As a supplier-qualification practice, request an assessment identifying the ingredient, manufacturing process, specifications, intended food uses, use levels, exposure assumptions, supporting safety evidence, and the people responsible for the conclusion. Ask which commercial grades and production sites the assessment covers, and request any relevant FDA correspondence. Compare that scope with the material actually purchased. Feed discrepancies into dual-source qualification and translate accepted identity and specification controls into ingredient addition verification.

Q.Is submitting a GRAS notice to FDA mandatory?+

Check the current US food GRAS notification provisions for the general program’s filing scope. For the US food route based on common use outside the United States before January 1, 1958, 21 CFR 170.30(c)(2) says a person reaching a GRAS conclusion should notify FDA: that provision recommends notification rather than requiring it. As a practical control, keep notification decisions and their rationale in the QA process, with a named owner for monitoring regulatory changes.

Q.Does an FDA no-questions letter mean that the ingredient has been approved?+

For document review, do not label an ingredient approved merely because a supplier presents a no-questions letter. Read the letter’s actual wording and identify the substance and uses it addresses. For US food, FDA’s overview distinguishes GRAS from the food-additive premarket approval pathway. As a records practice, retain the correspondence with its underlying assessment and avoid converting it into an unrestricted approval flag in the audit trail.

Q.Can unpublished studies support a scientific-procedure GRAS conclusion?+

Yes, as corroboration. For US food, 21 CFR 170.30(b) permits unpublished scientific data, information, or methods to corroborate general recognition of safety through scientific procedures. As an assessment practice, identify what each unpublished study adds: confirmation, uncertainty, or a potentially conflicting finding. Keep that analysis separate from a simple study inventory. A data-integrity risk assessment can help reviewers examine provenance, completeness, and whether the study material supports the interpretation assigned to it.

Q.How does a confidentiality position for notice data differ from generally available safety evidence?+

A confidentiality position concerns handling particular information; it is not the scientific basis for general recognition. For US food, 21 CFR 170.30(b) requires scientific-procedure GRAS recognition to rest on generally available and accepted scientific data, information, or methods, ordinarily published. As a dossier-management practice, distinguish the public scientific foundation from restricted supporting records. Use data-integrity controls to preserve provenance and a review workflow to document access decisions without confusing confidentiality with scientific acceptance.

Q.Can a food-use GRAS assessment be reused for a supplement or a non-US market?+

Reuse the assessment as technical background, not as an automatic market-access decision. As a regulatory-review practice, compare ingredient identity, manufacturing process, dose, exposure, target population, and product category before relying on earlier reasoning. Then commission a destination-specific assessment of the intended product. For planning, distinguish US supplement manufacturing from questions about EU novel-food status. These are separate review topics, not interchangeable labels attached to an ingredient’s safety dossier.

Q.Who decides whether a changed ingredient or formulation can return to operational use?+

As a manufacturing governance practice, the company’s designated human approvers make that decision under its procedures. Regulatory and safety reviewers assess whether the changed material remains within the accepted use assessment; quality and operations reviewers assess specifications, instructions, and implementation readiness. Route the decision through change control, recording unresolved issues and approval conditions. Update the recipe supersession log before implementing the accepted version. A completed workflow or supplier assurance should not substitute for that documented human decision.

Primary sources

  • 21 CFR 170.30 — Eligibility for classification as GRAS
  • 21 CFR 170.225 — GRAS notice contents
  • FDA: Generally Recognized as Safe (GRAS)
Talk to us about GRAS

Want to see how GRAS could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Where this term comes up
Dietary SupplementsFood Processing
Inside V5
  • → Document control — one version in force, every change signed and explained.
  • → QMS — quality records next to the work they concern.
Regulatory anchors
  • 21 CFR 170.30
  • 21 CFR 170 Subpart E
  • FD&C Act §201(s)
Related terms
  • → NDI Notification
  • → Structure/Function Claim

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC